MedPath

Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis

Phase 2
Completed
Conditions
Chronic Arsenic Poisoning
Interventions
Dietary Supplement: Garlic oil
Registration Number
NCT01748669
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Brief Summary

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed controls and healthy volunteers will be included for comparison.

Detailed Description

Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition. Till today there is no effective treatment.

Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of this study is to examine the effectiveness of oral administration of garlic oil to reduce body arsenic load and clinical symptoms of arsenical palmer keratosis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria
  • pregnancy
  • lactating mother
  • patient receiving treatment of arsenicosis
  • any other chronic disease like tuberculosis, diabetes mellitus, bronchial asthma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arsenic exposed controlsGarlic oilOne soft capsule of garlic oil (10 mg) daily for 12 weeks
Patients of palmer arsenical keratosisGarlic oilOne soft capsule of garlic oil (10 mg) daily for 12 weeks
Heathy volunteersGarlic oilOne soft capsule of garlic oil (10 mg) daily for 12 weeks
Primary Outcome Measures
NameTimeMethod
Change in the clinical symptom of keratosis in palm0 week (baseline) to 12 weeks (end)
Secondary Outcome Measures
NameTimeMethod
Change in biochemical parameters (blood sugar, cholesterol and transaminase) after treatment0 week (baseline), 12 weeks (end)
Adverse effects following treament0 week (baseline), 12 weeks (end)
Change in the amount of arsenic in nail0 week (baseline), 20 weeks (end)

Trial Locations

Locations (1)

Bangabandhu Sheikh Mujib Medical University

🇧🇩

Dhaka, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath